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RESUmo
Este estudo teve como objetivo identifi-
car a frequência de sintomas ansiosos e 
depressivos verificando a associação en-
tre a ansiedade-traço, sintomas atuais de 
depressão e ansiedade nos fibromiálgicos. 
Foram entrevistados 60 sujeitos com diag-
nóstico de fibromialgia no Ambulatório de 
Reumatologia da Universidade Federal de 
Sergipe, entre agosto de 2007 a março de 
2008, sendo aplicados dois questionários: 
Escala Hospitalar de Ansiedade e Depres-
são (EHAD) e o Inventário de Ansiedade 
Traço-Estado (IDATE-T). A frequência de 
sintomas depressivos e ansiosos foi, res-
pectivamente, de 50% e 86% para os fi-
bromiálgicos e a média do escore do traço 
ansioso foi de 59,38. Detectou-se associa-
ção entre a ansiedade-traço e estado. A 
ansiedade e a depressão foram sintomas 
frequentes nos pacientes com fibromialgia. 
Entretanto, a ansiedade revelou-se um sin-
toma secundário mais frequente que a de-
pressão, apresentando-se uma forma mais 
grave, sendo uma comorbidade que deve 
ser melhor valorizada e estudada.
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AbStRAct
The objective of this study was to identify 
the frequency of anxiety and depression 
symptoms by verifying the association be-
tween anxiety traits, current depression 
and anxiety symptoms in fibromyalgia pa-
tients. Interviews were performed with 60 
subjects diagnosed with fibromyalgia at the 
Rheumatology Outpatient Clinic at Univer-
sidade Federal de Sergipe between August 
2007 and March 2008, in which two ques-
tionnaires were administered: the Hospital 
Anxiety and Depression Scale (HADS) and 
the State-Trait Anxiety Inventory (STAI). 
The frequency of anxiety and depression 
symptoms was, respectively, 50% and 86% 
for individuals with fibromyalgia, and the 
mean trait-anxiety score was 59.38. An as-
sociation was observed between trait and 
state anxiety. Anxiety and depression were 
frequent symptoms among patients with 
fibromyalgia. However, anxiety appeared 
as a secondary symptom to depression, 
appearing in a more severe form, and, 
therefore, this comorbidity should be more 
valued and studied.
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RESUmEn 
Se objetivó identificar la frecuencia de sín-
tomas de ansiedad y depresión y verificar 
la asociación entre ansiedad-rasgo y sín-
tomas actuales de depresión y ansiedad 
en fibromiálgicos. Fueron entrevistados 
60 sujetos con diagnóstico de fibromial-
gia en Ambulatorio de Reumatología de 
Universidad Federal de Sergipe, de agosto 
2007 a marzo 2008. Se aplicaron dos cues-
tionarios: Escala Hospitalaria de Ansiedad 
y Depresión (EHAD) e Inventario de Ansie-
dad Rasgo-Estado (IDATE-T). La frecuencia 
de síntomas depresivos y ansiosos fue, 
respectivamente, 50% y 86% para los fi-
bromiálgicos y el promedio de puntaje del 
rasgo ansioso fue de 59,38. Se observó 
asociación entre ansiedad-rasgo y estado. 
La ansiedad y la depresión fueron síntomas 
frecuentes en pacientes con fibromialgia. 
Entretanto, la ansiedad fue un síntoma se-
cundario más frecuente que la depresión y 
se presentó de forma más grave, resultan-
do una comorbilidad que necesita ser más 
valorizada y estudiada.
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intRodUction
Fibromyalgia (FM) is a rheumatic syndrome of un-
known origin, characterized by diffuse and chronic muscu-
loskeletal pain. According to the criteria of the American 
College of Rheumatology (ACR), it is defined as diffuse 
pain for at least 3 months, besides the presence of sen-
sitivity in 11 or more out of 18 points that are painful to 
finger palpation, called tender points(1).  
Fibromyalgia mainly affects women between 40 and 
55 years old(1). In many industrialized countries, its preva-
lence ranges between 1 and 4% in the general population. 
It is the second most common rheumatological disorder, 
following on osteoarthritis(2). 
Fibromyalgia is constantly associated with other func-
tional syndromes. The disease can appear in isolation or 
associated with other syndromes, such as chronic head-
ache, thyroid dysfunction, irritable colon syndrome, de-
pression and anxiety(1). 
Chronic pain increases the risk of a comorbidity like 
anxiety and depression disorder(3). The fre-
quency of anxious and depressive symptoms 
in this population also increases. Studies ap-
point a close relation between fibromyalgia, 
anxiety and depression(4-6), which one third 
of patients report(5).
Anxiety is considered a common second-
ary symptom, which is frequently severe 
in fibromyalgia cases(5). The prevalence of 
these symptoms among patients ranges be-
tween 13% and 71%(7-9). Anxious symptoms 
can compromise the course of the disease. 
The presence of anxiety in fibromyalgia pa-
tients is related to a larger number of physi-
cal symptoms and stronger pain intensity(10), thus increas-
ing the severity of the disease.
Depression is similar to anxiety in fibromyalgia cas-
es. Patients with fibromyalgia reveal higher prevalence 
levels of depressive symptoms when compared with in-
flammatory and non-inflammatory rheumatic disease pa-
tients(11-12). The prevalence rate of depressive symptoms 
ranges between 20% and 80% in fibromyalgia patients(7-9). 
Like anxiety, depression also interferes in the presen-
tation of the disease. The worsening of physical condition-
ing, social and emotional functionality, pain and general 
health perception is associated with depression levels in 
fibromyalgia patients(13).
Although many international studies exist among the 
frequency of anxious and depressive symptoms among 
fibromyalgia patients, sociocultural and care differences 
among populations entail variations in the frequency of 
these symptoms, demanding a Brazilian study. Thus, the 
aim of this study was to identify the frequency of anxious 
and depressive symptoms and to verify the association 
between trait-anxiety and current depression and anxiety 
symptoms in fibromyalgia patients. 
mEtHod
This is an exploratory and cross-sectional study with a 
quantitative approach. The study population comprised 124 
subjects diagnosed with fibromyalgia who were under follow-
up at the Rheumatology Outpatient Clinic of Universidade 
Federal de Sergipe-UFS (Aracaju, SE, Brazil). In this group, 
60 subjects were interviewed who attended the monthly 
consultation between August/2007 and March/2008 at the 
rheumatology outpatient clinic. To be selected, the subjects 
should be over 18 and comply with the fibromyalgia diag-
nostic criteria of the American College of Rheumatology(1), 
as determined by a rheumatologist. This study received 
approval from the Ethics Committee for Research Involv-
ing Human Beings – UFS (No. 0045.0.107.000/2007) and all 
participants signed the informed consent term. After signing 
the term, the research instrument was applied, through an 
interview with the researcher.
The research instrument comprised two sections. The 
first section referred to socio-demographic 
data (gender, age range, marital status and 
education) and general health perception 
(categorized into precarious, reasonable, 
good, very good, excellent), measured with 
the help of a standardized questionnaire. 
The second section referred to the assess-
ment of depressive and anxious symptoms 
through the Hospital Anxiety and Depression 
Scale (HADS) and of trait-anxiety using the 
State-Trait Anxiety Inventory (STAI).
The Hospital Anxiety and Depression 
Scale (HADS), translated and validated in 
Brazil(14), was used in this study to check 
for anxiety and depression symptoms in the sample. This 
scale consists of a self-completed instrument with 14 
multiple-choice questions in two alternating sub-scales: 
one for state-anxiety (7 questions) and the other for state-
depression (7 questions). HADS scores range from 0 to 21 
points, subjects scoring < 7 are considered as having no 
significant clinical symptoms for anxiety and/or depres-
sion, scores ≥ 8 and ≤10 as mild symptoms, scores ≥11 and 
≤14 as moderate symptoms and scores ≥15 and ≤ 21 as 
severe anxiety and/or depression symptoms.
The State-Trait Anxiety Inventory (STAI), then, translat-
ed and validated in Brazil(15), was used to verify the fibro-
myalgia patients’ trait-anxiety. This instrument comprises 
40 assertions, divided in two sub-scales. The first assessed 
state-anxiety (20 questions) and refers to a transitory 
emotional state, characterized by subjective feelings of 
tension whose intensity can vary over time. The second 
sub-scale, then, assesses trait-anxiety (20 questions) and 
refers to a relatively stable personal inclination to react to 
stressful situations and to perceive a larger number of sit-
uations as threatening. It also assesses the subject’s trend 
to react to the situations of life anxiously (trait-anxiety). 
the worsening of 
physical conditioning, 
social and emotional 
functionality, 
pain and general 
health perception 
is associated with 
depression levels in 
fibromyalgia patients
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In this study, the choice was made to use only the trait-
anxiety sub-scale, as the HADS already assesses state-anx-
iety. The trait-anxiety sub-scale consists of 20 assertions 
describing personal feelings, with a total score ranging 
between 20 and 80 points, in which higher scores indicate 
greater anxiety levels. 
The collected data were typed in a worksheet, using 
the double-entry validation technique, in MS Excel XP. 
Next, the data were imported in SPSS (Statistical Package 
for the Social Science) for Windows version 15.0. Descrip-
tive statistics were used for all variables, including central 
trend (means) and dispersion (standard deviation) mea-
sures for quantitative variables. The possible correlation 
between STAI and HADS scores was analyzed using Pear-
son’s Correlation Coefficient, with significance set at 5%. 
RESULtS
Among the 60 interviewed subjects, the majority was 
female (87%), with a mean age (minimum and maximum) 
of 49.2 ± 13.8 (18 to 82) years. The predominant educa-
tion level was basic (67%) and the predominant marital 
status married (60%). Sociodemographic data and the 
perceived health status are described in Table 1. 
In Table 2, the frequency of depressive and anxious 
symptoms in displayed. It is observed that 50% of fibromy-
algia patients present depressive symptoms, 33% of mod-
erate to severe intensity. On the opposite, 88% of patients 
presented anxiety symptoms, 43% of severe intensity. 
                           
Figure 1 displays the distribution of Trait-STAI scores. 
The trait-anxiety score in the sample ranged between 46 
and 71, with a mean 59.38 and standard deviation 6.58. 
More than 75% of the patients scored higher than 60, 
demonstrating high levels of trait-anxiety.
Concerning the correlations between Trait-STAI and 
HADS scores, state-depression revealed a positive but 
not significant correlation with trait-anxiety (r =0.11 and 
p = 0.39). For state-anxiety, then, the correlation with 
trait-anxiety was positive and moderate (r =0.48 and p = 
0.0009), suggesting that the anxious profile is associated 
with high anxiety levels.
diScUSSion
Anxiety and depression symptoms are commonly ob-
served in patients suffering from chronic pain(3). There-
fore, it is suggested that psychological aspects of fibromy-
algia and chronic pain patients are similar. 
Table 1- Distribution of fibromyalgia patients according to socio-
-demographic characteristics and perceived general health status 
– Rheumatology Outpatient Clinic, Universidade Federal de Ser-
gipe – Aracaju, SE – 2007/2008
obs.: from August 2007 till march 2008
Variable N (%)
Age Range
< 42 15 (25%)
42 - 57 32 (53%)
> 57 13 (22%)
Gender
Male 8 (13%)
Female 52 (87%)
Education
Illiterate 3 (5%)
Primary education 40 (67%)
Secondary education 15 (25%)
Higher education 2 (3%)
Marital status
Single 13 (22%)
Married 36 (60%)
Separated 5 (8%)
Widowed 6 (10%)
Perceived health
Precarious 20 (33%)
Reasonable 30 (50%)
Good 7 (12%)
Very Good 3 (5%)
Excellent -
Table 2 – Distribution of fibromyalgia patients according to de-
pressive and anxious symptoms – Rheumatology Outpatient Cli-
nic, Universidade Federal de Sergipe – Aracaju, SE – 2007/2008
obs.: from August 2007 till march 2008
Scale Score N (%)
Depression (HADS)
< 7 30 (50%)
≥8  and ≤ 10 10 (17%)
≥11 and ≤ 14 15 (25%)
≥15 and ≤ 21 5 (8%)
Anxiety (HADS)
< 7 7 (12%)
≥8  and ≤ 10 7 (12%)
≥11 and ≤ 14 20 (33%)
≥15 and ≤ 21 26 (43%)
Figure 1 - Boxplot of trait-anxiety (T-STAI) score among fi-
bromyalgia patients – Rheumatology Outpatient Clinic, Univer-
sidade Federal de Sergipe – Aracaju, SE – 2007/2008
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The prevalence of psychological abnormalities, partic-
ularly depression, is high among fibromyalgia patients(7,16). 
Depression prevalence rates range between 20% and 
80%(7-9). In this study, 50% of fibromyalgia patients pre-
sented depressive symptoms, differing from findings in 
a study(9) that used the Hospital Anxiety and Depression 
Scale (HADS) as a depression assessment instrument and 
found depressive symptoms in 35.96%(9) of fibromyalgia 
patients. In studies developed in Salvador (Brazil)(17) and 
Mexico(11), the frequencies of depressive symptoms also 
diverged from the present study, with 39.2% and 78.38%, 
respectively. On the opposite, our findings supported the 
study(8) that, using the Hospital Anxiety and Depression 
Scale (HADS) as a depression assessment instrument and 
found that 30% of fibromyalgia patients presented moder-
ate to severe depressive symptoms. 
Possible explanations for the great variation in depres-
sion prevalence rates among studies include the different 
methods used for its assessment (scale of severity scores, 
self-assessment scale, self-report, diagnostic scales), dif-
ferent definitions adopted for depression and the sam-
pling bias (patients taking anti-depressive drugs), or even 
a combination of all of these factors. 
Despite the divergence among studies, the prevalence 
of depressive symptoms in fibromyalgia patients is actu-
ally high and becomes even more concerning when we 
compare it with the general population. In a Brazilian pop-
ulation-based study, researchers(18) found a prevalence 
rate of 29.4% among adults in the South of the country. 
This rate is lower than all rates found in fibromyalgia stud-
ies(8-9,11,17), suggesting that these patients experience more 
depressive symptoms than the general population. Al-
though it was not the depression diagnosis, but the pres-
ence of depressive symptoms that was assessed in this 
study, that does not decrease its clinical importance, as 
the limit between clinical depression and normal mood 
fluctuations is not clear. Thus, individuals who do not 
comply with diagnostic criteria for depression may pres-
ent depressive symptoms, but that does not means that 
the symptoms presented are not disabling.
The relation between fibromyalgia and depression has 
been proved in different studies(4-6). What can explain this 
relation is the relation between depression and pain, as 
the fibromyalgia syndrome is characterized by the obliga-
tory presence of diffuse and chronic pain. At least three 
theoretical branches exist to explain the relation between 
pain and depression: 1. Pain provokes depression, due to 
the stressful consequences it causes; 2. Depression and 
pain share the same pathophysiological roots; 3. Depres-
sion provokes pain, due to increased pain sensitivity(19).
In addition, fibromyalgia symptoms may be that in-
tense that they interfere in professional and social ac-
tivities, negatively affecting not only patients’ job perfor-
mance, but hampering the accomplishment of motor and 
cognitive tasks, destabilizing family relations and restrict-
ing social contact(20). Thus, fibromyalgia symptoms strong-
ly influence daily life and break with routine. Their conse-
quences tend to continue over time, due to the chronic 
nature of the disease(20). The fact that pain is not solved 
and that its consequences continue works towards the 
emergence of progressive feelings of hopelessness, pow-
erlessness and despair. This process leads to the appear-
ance of depression. Therefore, it has been suggested that 
pain and depression go along and that one aggravates the 
other(21).
Depressive disorders complicate the course of any dis-
ease through a range of possible mechanisms: reducing 
pain tolerance, making treatment adherence impossible 
and decreasing physical functionality(13). Besides, the pres-
ence of depression is related to the worsening of social 
and emotional functionality, mental health and general 
health perceptions(13). In the present study, 83% of fibro-
myalgia patients considered their health between precari-
ous and reasonable. Although the correlation between 
depressive symptoms and perceived health was not ana-
lyzed, it is suggested that bad health perception may be 
due to the high frequency of depressive symptoms in the 
sample.
Another frequent comorbidity in fibromyalgia patients 
is anxiety. This is considered a common secondary symp-
tom(5), with prevalence rates ranging between 13% and 
71%(7-9). In this study, 88% of fibromyalgia patients pre-
sented anxiety symptoms; 43% severe, suggesting that 
anxiety takes more severe forms than depression in fibro-
myalgia cases. This result is in line with a study developed 
in Salvador, where 87.5% of fibromyalgia patients indicat-
ed anxiety(17). They do differ from previous studies though, 
which used the Hospital Anxiety and Depression Scale 
(HADS) to assess anxious symptoms and found frequency 
levels of 57.93%(9) and 71%(8) for anxious symptoms in fi-
bromyalgia patients. 
In the assessment of trait-anxiety, most fibromyalgia 
patients (75%) scored higher than 60, also suggesting the 
high frequency of the anxious profile, as scores on the 
Trait-STAI sub-scale range between 20 and 80 points. In 
studies developed in São Paulo(22) and Germany(10), using 
the STAI, mean scores (standard deviation) of 53.18 (12.6)
(22) and 28.65 (12.39)(10) were observed for the trait-anxiety 
sub-scale. These levels are inferior to the present findings, 
with a mean trait-anxiety score of 59.37 and a standard 
deviation twice as low. The difference in Trait-STAI scores 
and anxious symptom frequencies can be due to educa-
tional level differences in the samples, different knowl-
edge levels about the disease or the fact that patients are 
receiving pharmacological or non-pharmacological treat-
ment for anxiety at the time of research. 
In the present study, a relation was also observed 
between the presence of current anxious symptoms, as-
sessed through the Hospital Anxiety and Depression Scale 
(HADS), and trait-anxiety, assessed through the Trait-STAI. 
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Current anxiety symptoms (state-anxiety) refer to a transi-
tory and conscious emotional state that flows over time, as-
sociated with unpleasant feelings of tension, nervousness, 
concern and increased activity of the sympathetic nervous 
system(15). Trait-anxiety, then, refers to relatively stable indi-
vidual differences with regard to anxiety. These are trends 
to react to situations perceived as threatening which each 
individual develops based on his/her personal experiences. 
This also characterizes individuals who are hypersensitive 
to stimuli and psychologically more reactive. The develop-
ment of the anxiety trait and its maintenance are directly 
related with the individual’s past experiences, perception 
of these experiences and the resulting conditioning(15).
The relation found between state and trait-anxiety 
can be explained by the fact that personality character-
istics (trait) frequently interact with the situational and 
environmental factors people experience. This interaction 
between the subject’s personal characteristics and the an-
swers (s)he needs to give to the environment (s)he is in 
determines that person’s behavior and can mold new trait 
patterns(15). In other words, the continuation of an aggres-
sive behavior (state) can lead to the development of an 
anxious profile. Besides, an individual with a high level of 
anxious trait normally reacts to a threatening situation by 
increasing his/her anxious state.
The anxiety reaction is normally present when pain 
is triggered. As the origin of fibromyalgia is unknown, its 
cure is uncertain and pain is the main symptom, the dis-
ease provokes feelings of ignorance and insecurity in pa-
tients(16), which can arouse anxiety.
The presence of anxiety can influence pain percep-
tions, decreasing the pain threshold(10), and be related 
with an increased number of physical symptoms associ-
ated with fibromyalgia(10), as well as with functional com-
mitment(13). Hence, due to anxiety, patients’ perceptions 
of their somatic symptoms are more intense and disturb-
ing. The relation between anxiety and physical function, 
bodily pain, social behavior and lack of correlation with 
vitality, emotional role and mental health suggest that 
these patients somatize their anxiety. Thus, fibromyalgia 
patients present less pain in comparison with osteoarthri-
tis and rheumatoid arthritis patients, but experience more 
physical dysfunctions. This can explain why these patients 
frequently present somatic complaints like headache and 
parestesia(12).
Anxiety disorders have been relatively neglected in 
chronic pain research in general, although awareness 
about the strong association between anxiety and chronic 
pain conditions is growing. Anxiety and depression are im-
portant comorbidities of fibromyalgia and demand assess-
ment and treatment. Not only pharmacological, but also 
non-pharmacological interventions, like behavioral cogni-
tive therapy, are effective to reduce anxiety and depres-
sion in fibromyalgia patients(6).
concLUSion
Anxiety and depression were frequent symptoms in 
fibromyalgia patients. Anxiety, however, was a more fre-
quent secondary symptom and took more severe forms. 
Therefore, the comorbidity should be valued and stud-
ied better. The relation observed between trait and state 
anxiety demonstrates that the anxiety state should be 
assessed, as it can work towards the appearance of an 
anxious profile. Due to the impact these psychological 
disorders can cause on the presentation of the disease, 
whether through the intensification of pre-existing symp-
toms or the production of additional ones, an interprofes-
sional approach of anxious and depression symptoms is 
extremely important, for the assessment as well as the 
treatment of fibromyalgia patients. 
In the context of this interprofessional approach, nurs-
es can intermediate contact between patients and other 
health professionals as, when screening from anxious and 
depressive symptoms, they can identify the need for for-
warding to other professionals with a view to reaching 
the diagnosis of these psychological disorders and their 
adequate treatment. Knowledge about the present study 
results also contributes to direct nursing care for this pop-
ulation. Nurses can guide action planning for the reduc-
tion of depression and anxiety symptoms. Nurses’ impor-
tant role as educators should be highlighted, as clarifying 
patients’ doubts about fibromyalgia can be an effective 
way to decrease anguish and uncertainty among these 
patients. 
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